CHRS
#3491
Coherus Oncology, Inc. - Common Stock
1.6 5 USD
-0.01%
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
-1.20%
Monthly Change
+14.58%
6 month change
+2.48%
Year Change
+2.48%
Previous Close
1.6 7
Open
1.6 6
Low
1.6 5
High
1.6 8
Volume
446
Financials
- Market Capitalization 254.51 M
- Employee 145
- Founded 2010
- CEO Dennis Lanfear
- Website www.coherus.com
- Headquarter Delaware, United States
- FIGI BBG0063N8V69
- Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
1.03
Price to sales ratio
4.37
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 3480 |  NKTX Nkarta, Inc. - Common Stock | 3.66 USD | +8.28% | +28.42% | +51.24% | +106.78% | 261.86 M USD | ||
| 3487 |  AVXL Anavex Life Sciences Corp. - Common Stock | 2.72 USD | +0.37% | +5.43% | +2.64% | -73.62% | 252.07 M USD | ||
| 3504 |  FULC Fulcrum Therapeutics, Inc. - Common Stock | 3.74 USD | -0.80% | +2.75% | +7.16% | -53.13% | 249.21 M USD | ||
| 3515 |  KPTI Karyopharm Therapeutics Inc. - Common Stock | 10.65 USD | +5.97% | +11.52% | +22.70% | +10.48% | 241.36 M USD |
Frequently asked questions about Coherus Oncology, Inc. - Common Stock
What is the Coherus Oncology, Inc. - Common Stock stock price today?
The current price of Coherus Oncology, Inc. - Common Stock (CHRS) is 1.65. Over the past 24 hours, the stock has changed by -1.20%. Follow the CHRS chart for real-time price dynamics.
What is the stock ticker of Coherus Oncology, Inc. - Common Stock?
Coherus Oncology, Inc. - Common Stock trades under the ticker CHRS. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Coherus Oncology, Inc. - Common Stock stock going up?
CHRS has changed by +14.58% over the last week, +14.58% over the last month, and +2.48% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was Coherus Oncology, Inc. - Common Stock net income for the last quarter?
Coherus Oncology, Inc. - Common Stock reported net income of -38.33 M for the last quarter. The previous quarter showed -37.64 M, which means net income changed by -1.82%.
How many employees does Coherus Oncology, Inc. - Common Stock have?
As of the latest available data, Coherus Oncology, Inc. - Common Stock has 145 employees. Workforce size can provide additional context about the company's scale and operations.
What is Coherus Oncology, Inc. - Common Stock EBITDA?
Coherus Oncology, Inc. - Common Stock EBITDA is -35.55 M, and its EBITDA margin is -288.8%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Coherus Oncology, Inc. - Common Stock stock?
You can buy Coherus Oncology, Inc. - Common Stock (CHRS) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Coherus Oncology, Inc. - Common Stock stock?
Investing in Coherus Oncology, Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the CHRS chart and related analysis on metatrader.com as part of your research.